OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening
Emiel Vanhulle, Joren Stroobants, Becky Provinciael, et al.
Antiviral Research (2022) Vol. 203, pp. 105342-105342
Open Access | Times Cited: 12
Emiel Vanhulle, Joren Stroobants, Becky Provinciael, et al.
Antiviral Research (2022) Vol. 203, pp. 105342-105342
Open Access | Times Cited: 12
Showing 12 citing articles:
The Chiral 5,6-Cyclohexane-fused Uracil Ring-System: a Molecular Platform with Promising Activity against SARS-CoV-2
Enrico Marcantonio, Debora Guazzetti, Crescenzo Coppa, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117302-117302
Closed Access | Times Cited: 1
Enrico Marcantonio, Debora Guazzetti, Crescenzo Coppa, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117302-117302
Closed Access | Times Cited: 1
Development of Fluorescence-Based Assays for Key Viral Proteins in the SARS-CoV-2 Infection Process and Lifecycle
Mingzhenlong Deng, Chuang Zhang, Wanli Yan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2850-2850
Open Access | Times Cited: 4
Mingzhenlong Deng, Chuang Zhang, Wanli Yan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2850-2850
Open Access | Times Cited: 4
The Potential of Metal-Organic Framework Mil-101(Al)-Nh2 in the Forefront of Antiviral Protection of Cells Via Interaction with Sars-Cov-2 Spike Rbd Protein and Their Antibacterial Action Mediated with Hypericin and Photodynamic Treatment
Veronika Huntošová, Anass Benziane, Lubos Zauška, et al.
(2025)
Closed Access
Veronika Huntošová, Anass Benziane, Lubos Zauška, et al.
(2025)
Closed Access
SARS-CoV-2 Establishes a Productive Infection in Hepatoma and Glioblastoma Multiforme Cell Lines
Olga A. Smirnova, Olga N. Ivanova, Irina T. Fedyakina, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 632-632
Open Access | Times Cited: 10
Olga A. Smirnova, Olga N. Ivanova, Irina T. Fedyakina, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 632-632
Open Access | Times Cited: 10
Carbohydrate-binding protein from stinging nettle as fusion inhibitor for SARS-CoV-2 variants of concern
Emiel Vanhulle, Thomas D’huys, Becky Provinciael, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 15
Emiel Vanhulle, Thomas D’huys, Becky Provinciael, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 15
Novel Polymyxin-Inspired Peptidomimetics Targeting the SARS-CoV-2 Spike:hACE2 Interface
Kelly Bugatti, Andrea Sartori, Lucia Battistini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8765-8765
Open Access | Times Cited: 4
Kelly Bugatti, Andrea Sartori, Lucia Battistini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8765-8765
Open Access | Times Cited: 4
Antiviral activity of natural compounds extracted from Mediterranean medicinal plants against SARS-CoV-2
Stephanie Ghio, Jean‐Pierre Brincat, Yüksel Çetin, et al.
Academia Biology (2024) Vol. 2, Iss. 3
Open Access | Times Cited: 1
Stephanie Ghio, Jean‐Pierre Brincat, Yüksel Çetin, et al.
Academia Biology (2024) Vol. 2, Iss. 3
Open Access | Times Cited: 1
Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants
Emiel Vanhulle, Jordi Doijen, Joren Stroobants, et al.
Antiviral Research (2023) Vol. 213, pp. 105587-105587
Open Access | Times Cited: 2
Emiel Vanhulle, Jordi Doijen, Joren Stroobants, et al.
Antiviral Research (2023) Vol. 213, pp. 105587-105587
Open Access | Times Cited: 2
Preclinical discovery and development of nirmatrelvir/ritonavir combinational therapy for the treatment of COVID-19 and the lessons learned from SARS-COV-2 variants
Pasquale Pagliano, Anna Maria Spera, Carmine Sellitto, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 12, pp. 1301-1311
Closed Access | Times Cited: 2
Pasquale Pagliano, Anna Maria Spera, Carmine Sellitto, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 12, pp. 1301-1311
Closed Access | Times Cited: 2
Management of Glioblastoma Multiforme During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: A Review of the Literature
Bardia Hajikarimloo, Farzan Fahim, Mohammadamin Sabbagh Alvani, et al.
World Neurosurgery (2023) Vol. 178, pp. 87-92
Closed Access | Times Cited: 1
Bardia Hajikarimloo, Farzan Fahim, Mohammadamin Sabbagh Alvani, et al.
World Neurosurgery (2023) Vol. 178, pp. 87-92
Closed Access | Times Cited: 1
Carbohydrate-Binding Protein from Stinging Nettle as Fusion Inhibitor for SARS-CoV-2 Variants of Concern
Emiel Vanhulle, Thomas D’huys, Becky Provinciael, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Emiel Vanhulle, Thomas D’huys, Becky Provinciael, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants
Emiel Vanhulle, Jordi Doijen, Joren Stroobants, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Emiel Vanhulle, Jordi Doijen, Joren Stroobants, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
